[Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management]
- PMID: 32466862
- PMCID: PMC7836827
- DOI: 10.1016/j.otorri.2020.04.003
[Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management]
Abstract
There is debate as to whether olfactory dysfunction should be considered a symptom of COVID-19 infection, given the implications for managing the symptom itself, for diagnostic testing, and for implementing isolation measures. We undertook a systematic literature review of the articles indexed in PubMed on olfactory disorders in viral respiratory tract conditions, with special emphasis on COVID-19. The main objective was to find evidence of clinical interest to support the relationship between anosmia and COVID-19. Olfactory disorders in upper respiratory tract infections are frequent, most caused by obstruction due to oedema of the nasal mucosa. Occasionally, post-viral sensorineural olfactory dysfunction occurs, with a variable prognosis. The evidence on anosmia in COVID-19 patients is extremely limited, corresponding to a level 5 or D of the Centre for Evidence-Based Medicine. According to the various medical societies that have issued reports on the subject, it seems reasonable to apply isolation, hygiene and social distancing measures in patients with recent olfactory disorders as the only symptom, although the usefulness of diagnostic tests for this type of patient should be studied.
Keywords: Anosmia; COVID 19; Post-viral olfactory dysfunction.
© 2020 Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello. Published by Elsevier España, S.L.U. All rights reserved.
Comment in
-
Do young women with COVID-19 have a higher risk of presenting olfactory dysfunction?Acta Otorrinolaringol Esp (Engl Ed). 2022 Jan-Feb;73(1):66-67. doi: 10.1016/j.otoeng.2022.01.002. Epub 2022 Jan 24. Acta Otorrinolaringol Esp (Engl Ed). 2022. PMID: 35190092 Free PMC article. No abstract available.
-
The aftermath of COVID-19: between anosmia and ageusia.Acta Otorrinolaringol Esp (Engl Ed). 2022 May-Jun;73(3):200. doi: 10.1016/j.otoeng.2021.07.003. Epub 2022 Mar 3. Acta Otorrinolaringol Esp (Engl Ed). 2022. PMID: 35577438 Free PMC article. No abstract available.
References
-
- O’Donovan J., Tanveer S., Jones N., Hopkins C., Senior B.A., Wise S.K., et al. What is the evidence for anosmia (loss of smell) as a clinical feature of COVID-19? Available from: https://www.cebm.net/covid-19/what-is-the-evidence-for-anosmia-loss-of-s....
-
- Holbrook E.H., Leopold D.A. An updated review of clinical olfaction. Curr Opin Otolaryngol Head Neck Surg. 2006;14:23–28. - PubMed
-
- Holbrook E.H., Leopold D.A. Anosmia: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2003;11:54–60. - PubMed
-
- Doty R.L. Office procedures for quantitative assessment of olfactory function. Am J Rhinol. 2007;21:460–473. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
